2796 Stock Overview
Manages dispensing pharmacies in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Pharmarise Holdings Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥616.00 |
| 52 Week High | JP¥722.00 |
| 52 Week Low | JP¥523.00 |
| Beta | 0.17 |
| 11 Month Change | -2.69% |
| 3 Month Change | 1.65% |
| 1 Year Change | -6.67% |
| 33 Year Change | -16.76% |
| 5 Year Change | -3.75% |
| Change since IPO | 21.31% |
Recent News & Updates
Shareholder Returns
| 2796 | JP Consumer Retailing | JP Market | |
|---|---|---|---|
| 7D | 0.5% | 0.4% | -0.4% |
| 1Y | -6.7% | 10.9% | 11.4% |
Return vs Industry: 2796 underperformed the JP Consumer Retailing industry which returned 10.9% over the past year.
Return vs Market: 2796 underperformed the JP Market which returned 11.4% over the past year.
Price Volatility
| 2796 volatility | |
|---|---|
| 2796 Average Weekly Movement | 1.7% |
| Consumer Retailing Industry Average Movement | 3.3% |
| Market Average Movement | 3.8% |
| 10% most volatile stocks in JP Market | 7.6% |
| 10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 2796 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 2796's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 1,848 | Masayuki Akiyama | www.pharmarise.com |
Pharmarise Holdings Corporation manages dispensing pharmacies in Japan. Its dispensing pharmacies provide patients with dispensing services based on prescriptions drawn up by medical institutions. The company also manages drug stores and convenience stores.
Pharmarise Holdings Corporation Fundamentals Summary
| 2796 fundamental statistics | |
|---|---|
| Market cap | JP¥6.93b |
| Earnings (TTM) | -JP¥605.00m |
| Revenue (TTM) | JP¥56.23b |
0.1x
P/S Ratio-11.4x
P/E RatioIs 2796 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2796 income statement (TTM) | |
|---|---|
| Revenue | JP¥56.23b |
| Cost of Revenue | JP¥47.77b |
| Gross Profit | JP¥8.46b |
| Other Expenses | JP¥9.06b |
| Earnings | -JP¥605.00m |
Last Reported Earnings
Aug 31, 2024
Next Earnings Date
Dec 25, 2024
| Earnings per share (EPS) | -53.81 |
| Gross Margin | 15.04% |
| Net Profit Margin | -1.08% |
| Debt/Equity Ratio | 146.8% |
How did 2796 perform over the long term?
See historical performance and comparison